Can a Weight-Loss drug slow prostate cancer? a trial investigates
Disease control
Not yet recruiting
This trial explores whether semaglutide, a drug approved for weight management, can affect tumor biology when given for 3 to 6 months before prostate removal surgery. About 20 men with intermediate-risk localized prostate cancer and a BMI over 35 will receive weekly injections. R…
Phase: EARLY_PHASE1 • Sponsor: Banner Health • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC